Literature DB >> 30918860

Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study.

Harry Kellam1.   

Abstract

Objective: To explore the bi-directional between pancreatic cancer (PC) and diabetes mellitus (DM); focusing on the prevalence, temporal association and impact on survival outcomes.
Methods: A retrospective audit of pancreatic cancer patients from the institutional clinical database (CaNISC) between January 2012 and April 2018.
Results: A total of 131 patients were analysed, 58 patients carried a diagnosis of diabetes mellitus. The median overall survival for diabetes mellitus patients was 12.0 months (95 CI, 5.9 to 18.1 months) in comparison to 13.0 months (95% CI, 8.6 to 17.3 months) in non-diabetes mellitus patients (p = 0.334).
Conclusion: There was no significant difference in the overall survival between DM and non-DM patients.

Entities:  

Keywords:  Association; Cancer; Diabetes; Outcome; Pancreas; Treatment

Year:  2018        PMID: 30918860      PMCID: PMC6405397          DOI: 10.1007/s40200-018-0366-2

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  15 in total

1.  Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.

Authors:  Samantha L Bowker; Sumit R Majumdar; Paul Veugelers; Jeffrey A Johnson
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

2.  Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study.

Authors:  Allen Hwang; Vivek Narayan; Yu-Xiao Yang
Journal:  Cancer       Date:  2012-08-01       Impact factor: 6.860

3.  Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.

Authors:  Monica Dandona; David Linehan; William Hawkins; Steven Strasberg; Feng Gao; Andrea Wang-Gillam
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

4.  Obesity adversely affects survival in pancreatic cancer patients.

Authors:  Robert R McWilliams; Martha E Matsumoto; Patrick A Burch; George P Kim; Thorvardur R Halfdanarson; Mariza de Andrade; Kaye Reid-Lombardo; William R Bamlet
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

5.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

6.  Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.

Authors:  S Radulovic; A Nagy; B Szoke; A V Schally
Journal:  Cancer Lett       Date:  1992-03-15       Impact factor: 8.679

7.  Diabetes and pancreatic cancer survival: a prospective cohort-based study.

Authors:  A T Toriola; R Stolzenberg-Solomon; L Dalidowitz; D Linehan; G Colditz
Journal:  Br J Cancer       Date:  2014-05-01       Impact factor: 7.640

Review 8.  Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Yixiang Mao; Min Tao; Xiaoyan Jia; Hong Xu; Kai Chen; Hongwei Tang; Donghui Li
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

9.  Impact of diabetes mellitus on the outcome of pancreatic cancer.

Authors:  Muhammad Shaalan Beg; Alok Kumar Dwivedi; Syed Arif Ahmad; Sadia Ali; Olugbenga Olowokure
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

10.  Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis.

Authors:  Hui Shen; Ming Zhan; Wei Wang; Dong Yang; Jian Wang
Journal:  Onco Targets Ther       Date:  2016-03-22       Impact factor: 4.147

View more
  2 in total

1.  Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.

Authors:  Zhenluo Jiang; Lili Shen; Shuwei Wang; Shengdong Wu; Yaoren Hu; Junming Guo; Liyun Fu
Journal:  Cancer Med       Date:  2019-10-08       Impact factor: 4.452

2.  Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1.

Authors:  Qian Yu; Zhong Zhang; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.